Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report

Saved in:

Bibliographic Details
Main Authors:	Gu, Xiaodong (Author) , Wang, Wenxian (Author) , Wu, Wei (Author) , Zhang, Yiping (Author) , Shao, Lan (Author) , Santarpia, Mariacarmela (Author) , Christopoulos, Petros (Author) , Myall, Nathaniel J. (Author) , Shi, Zhiyong (Author) , Lou, Guangyuan (Author)
Format:	Article (Journal)
Language:	English
Published:	[May 2022]
In:	Translational Lung Cancer Research Year: 2022, Volume: 11, Issue: 5, Pages: 902-909
ISSN:	2226-4477
DOI:	10.21037/tlcr-22-288
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21037/tlcr-22-288 Verlag, lizenzpflichtig, Volltext: https://tlcr.amegroups.com/article/view/64599
Author Notes:	Xiaodong Gu, Wenxian Wang, Wei Wu, Yiping Zhang, Lan Shao, Mariacarmela Santarpia, Petros Christopoulos, Nathaniel J. Myall, Zhiyong Shi, Guangyuan Lou

Description
Summary:	Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
Item Description:	Gesehen am 06.09.2022
Physical Description:	Online Resource
ISSN:	2226-4477
DOI:	10.21037/tlcr-22-288

Similar Items